Why human-in-the-loop AI is essential for compliance software

Compliance teams are increasingly having to make decisions about AI, whether it arrives as a platform feature, a bolt-on tool, or something a team member starts using on their own initiative.

For a quality manager, the question is rarely "should we use AI?" any more. It's "how much can we trust it, and who's accountable when it gets something wrong?"

When it comes to document control, this matters. Every approval, revision and signature on a controlled document carries compliance weight, backed by an audit trail that a regulator can inspect at any time. When AI starts helping with document classification, drafting, review routing or approval recommendations, it's stepping directly into that decision, not sitting alongside it.

A wrong recommendation from a shopping app is an inconvenience. A wrong recommendation on a controlled document, or a deviation report flagged as low risk when it isn't, can become an issue at your next audit.

This is where "human-in-the-loop" AI becomes essential.

What does "human-in-the-loop" mean in document control?

Human-in-the-loop means a qualified person reviews and approves AI-generated output before it is used to make a decision on an official document. The AI can suggest, flag, draft or prioritise, but it doesn't have the final word. This is different from two related ideas:

• Human-on-the-loop, where a person monitors ongoing performance rather than reviewing every output. Fine for low-risk tasks like folder suggestions, where an error is minor and easily corrected.
• Human-in-command, where a person retains authority to override or shut down the system, even without reviewing each decision.

Most document control workflows need a blend of these depending on risk. Deciding whether a document is ready for final approval or whether a deviation qualifies as a CAPA needs human-in-the-loop review, because the record produced becomes part of the company’s official, auditable history.

Why regulators are focusing on this now

In its January 2025 draft guidance on AI-enabled device software, the FDA highlighted that reviewers need to understand how a human interprets an AI's output and ultimately makes the decision, not just how the model performs in isolation. On 14 January 2026, the FDA and EMA jointly published ten guiding principles for AI in drug development, with "human-centric by design" listed first.

Separately, Article 14 of the EU AI Act requires that high-risk AI systems be built so that a trained person can monitor them and intervene when necessary, effectively ruling out fully automated, black-box decisions in sensitive settings.

The consensus is clear: AI can assist a decision, but it can't become the decision-maker of record. For document control, that means AI can support classification, drafting, or review routing, but the approval that puts a document into effect still requires a named, accountable human signature.

What goes wrong without adequate human oversight

The risks aren't hypothetical. In February 2025, the FDA issued a warning letter to an AI-based health screening company for marketing its device beyond its regulatory clearance, and for gaps in its quality system, an illustration of how quickly small gaps can escalate when AI influences decisions without the infrastructure to support them.

A few failure modes recur:

• Automation bias: People tend to overtrust an output simply because it came from a machine. A reviewer expected to "approve" an AI suggestion with no real opportunity to challenge it can end up worse off than with no AI at all, since oversight that exists on paper but not in practice satisfies neither a regulator nor the organisation.
• Opaque reasoning: If a reviewer can't see why an AI system reached its conclusion, they can't meaningfully evaluate it, which is why explainability keeps recurring in AI guidance. This matters more, not less, when the AI can also fabricate plausible-sounding but incorrect information, or misjudge a document type or deviation it hasn't seen the like of before.
• Legal and contextual nuance: Deciding whether a deviation or non-conformance meets a regulatory threshold often depends on context that an algorithm doesn't have, such as jurisdiction or the relationship between the parties involved. This is exactly the kind of judgement that needs a human in the loop rather than an automated threshold check.

Where human oversight matters most in document control

Not every AI-assisted task in a document control system carries the same risk:

• Document approvals and e-signatures: AI might flag missing signatures or outdated references, but the approval itself needs to sit with a named, authorised person. Under ISO 13485:2016 and the FDA's Quality Management System Regulation (21 CFR Part 820), which now incorporates ISO 13485 by reference, document approvals require a designated reviewer whose sign-off is recorded; neither provides for an algorithm to serve that role.
• CAPA and non-conformance classification: AI might triage issues by likely severity, but deciding whether something requires a formal CAPA is a judgement call for a quality professional.
• Training record checks: AI might confirm required training exists before a document goes live, but exceptions require human sign-off.
• Audit trail review: AI might flag unusual patterns, such as a document approved unusually quickly, but interpreting whether that's a problem is a human task.

In each case, the AI's job should be to reduce the manual burden of finding relevant information. The human's job is to decide what it means, and to be the name behind the approval when a regulator asks.

Building human oversight into compliance software

Several key principles keep human oversight genuinely effective rather than symbolic:

Make the escalation point unavoidable

Every AI-assisted step should have a clear point at which human review occurs before the document status changes. If it's easy to skip, it will get skipped under deadline pressure.

Preserve the reasoning, not just the recommendation

A reviewer approving an AI suggestion needs to see the basis for it. A recommendation without clear reasoning invites either blind trust or blanket rejection.

Keep the audit trail intact

Any AI-influenced decision should show what the AI suggested, what the human reviewed, and what was approved, exactly the kind of record regulators increasingly ask for.

Match oversight to risk

Low-risk, high-volume tasks can tolerate lighter monitoring. Anything with regulatory or safety consequences needs direct review.

Getting this right depends on what the underlying document control system actually allows for. A system that logs every AI suggestion, preserves the full approval history, and keeps final sign-off with a named person makes oversight straightforward to demonstrate during an audit.

Cognidox has been built around exactly this: a single, auditable record for every regulated document, with defined approval routes and a full history of who did what and when.

Conclusion

Human-in-the-loop means a qualified person reviews and approves AI output before it becomes an official document or decision, rather than the AI deciding on its own.

Regulators, including the FDA and EMA, and frameworks such as the EU AI Act, are converging on the same expectation: AI can assist a compliance decision, but a human has to remain accountable for making it.

That matters because automation bias and opaque AI reasoning are well-documented failure modes, and oversight that exists only on paper can leave an organisation worse off than having no AI involved at all.

The right level of oversight depends on risk. Low-risk, high-volume tasks can get away with lighter monitoring, but anything with regulatory or safety consequences requires direct human review.

If you want clear human accountability built into your document control as you scale, book a demo with Cognidox to see how audit-ready document control works in practice.

FAQs

1. Does using AI in a QMS automatically mean more regulatory scrutiny?

Using AI in a QMS doesn’t automatically mean more regulatory scrutiny, but it raises the bar for documentation. Regulators increasingly ask organisations to show how AI-assisted decisions are reviewed, by whom, and with what evidence.

2. Is a human-in-the-loop review required by law?

A human-in-the-loop review isn’t necessarily required by law. Requirements vary by jurisdiction and risk level. The EU AI Act sets out human oversight obligations for high-risk AI systems, and FDA guidance increasingly expects evidence of human-AI workflows. Treat this as an evolving expectation and check current guidance for your specific product and market.

3. What's the difference between human-in-the-loop and a person simply "rubber-stamping" AI output?

The difference between human-in-the-loop and a person simply “rubber-stamping” AI output is whether the reviewer has genuine visibility into the AI's reasoning and a real opportunity to disagree. A review step that exists in name only doesn't provide the accountability regulators are looking for, even if a human technically clicked "approve".